Arts Jul 27 Wu-Tang Clan album sale pays off Martin Shkreli’s court debt By Larry Neumeister, Associated Press
Nation Jul 18 Court upholds sentencing of drug company CEO Martin Shkreli Martin Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran. By Associated Press
Nation Mar 09 Martin Shkreli, pharmaceutical chief who increased price of lifesaving drug, sentenced to 7 years in prison Martin Shkreli, the self-promoting pharmaceutical executive notorious for trolling critics online, was convicted in a securities fraud case last year unconnected to the price increase dispute. By Tom Hays, Colleen Long, Associated Press
Health Aug 08 Column: How Big Pharma is hindering the fight against the opioid epidemic While opioids have become easier to obtain through illicit markets, a drug that could save countless lives has become increasingly out of reach. By Robin Feldman, The Conversation
World Aug 04 Watch 4:54 News Wrap: Venezuela’s controversial new assembly convenes In our news wrap Friday, Venezuela's new constitutional assembly convened for the first time. The governing body has sweeping powers that opponents fear will be used to impose a dictatorship for President Nicolas Maduro. Also, a federal appeals court in… By PBS News Hour
Aug 23 Congress scolds pharmaceutical company’s price hike on EpiPens By Ed Silverman, STAT Mylan has raised the list price of EpiPens more than 450 percent since 2004, after adjusting for inflation, according to Elsevier’s Gold Standard Drug Database. A pack of two EpiPens cost about $100 in today’s dollars in 2004, but the… Continue reading
Jul 10 Advocates hope shaming drugmakers discourages price spikes By Jonathan J. Cooper, Associated Press Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly. Continue reading
May 03 Shkreli’s old company is sued for breaching sales contract for Daraprim By Ed Silverman, STAT Turing Pharmaceuticals is being sued for more than $20 million by the drug maker that sold it the rights to Daraprim. Continue reading
Feb 26 Candidates’ prescription drug price plans may miss the mark By Julie Rovner, KFF Health News Most of the people running for president say they want to do something about the rising cost of prescription drugs. But most of their proposals probably won’t work because they don’t address the dynamics behind these price increases. Continue reading
Feb 04 Watch 3:59 News Wrap: Embattled pharma CEO takes Fifth before Congress By PBS News Hour In our news wrap Thursday, embattled ex-Turing Pharmaceuticals CEO Martin Shkreli pleaded the Fifth when called to testify before Congress on drug pricing protocols. Also, 12.7 million Americans signed up for private health insurance under the Affordable Care Act this… Continue watching